TZThembile Zini

Thembile Zini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thembile Zini has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors of Treatment Outcomes Among HIV-Positive Patients with Drug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: A Retrospective Cohort Study

    by Thembile Zini, Urgent Tsuro, Lindiwe Modest Faye, Ncomeka Sineke, Monwabisi Faleni

    Background: Drug-resistant tuberculosis (DR-TB) remains a major public health challenge in South Africa, particularly in rural settings with high HIV co-infection rates. Understanding predictors of treatment response among people living with HIV is essential for improving clinical management and programmatic outcomes. This study aimed to identify socio-demographic and clinical predictors of treatment outcomes among HIV-positive individuals diagnosed with multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) in rural Eastern Cape Province, South Africa. Methods: A retrospective cohort study was conducted using routinely collected clinical records of DR-TB patients initiated on treatment between January 2020 and December 2024 at two public healthcare facilities. A total of 239 patients with complete treatment outcome data were included. Treatment outcomes were classified as favourable (cured or treatment completed) or unfavourable (death, treatment failure, or loss to follow-up). Descriptive statistics were used to summarise patient characteristics, while univariate and multivariable logistic regression analyses were performed to identify factors associated with treatment outcomes. Results: Most participants were aged ≤ 39 years (58%), male (60%), unemployed (90%), and without income (80%). MDR-TB accounted for 40% of cases, rifampicin-resistant-TB (RR-TB) for 53%, and XDR-TB for 7.1%. Multivariable analysis showed that XDR-TB was the strongest independent predictor of unfavourable treatment outcome (AOR = 0.18; 95% CI: 0.06–0.58; p = 0.004). Income status was also significantly associated with outcome, with participants reporting some incomes having lower odds of favourable outcomes (AOR = 0.46; 95% CI: 0.23–0.92; p = 0.036). The model demonstrated modest predictive performance (AUC = 0.67). Conclusions: These findings highlight the dominant influence of resistance phenotype, particularly XDR-TB, on treatment prognosis among HIV-positive DR-TB patients in rural Eastern Cape. Integrating early resistance profiling, intensified clinical management of XDR-TB, and socioeconomic support mechanisms may improve treatment outcomes in high-burden rural settings.


  • Open Access

    Predictive Analysis of Determinants of Treatment Outcomes in DR-TB/HIV Coinfection in a High TB Setting of Eastern Cape

    by Thembile Zini, Lindiwe Modest Faye, Monwabisi Faleni

    Background: Drug-resistant tuberculosis (DR-TB) remains a major threat to TB control, with success rates below global targets. While clinical determinants such as resistance type are well established, the role of social and behavioral factors is less clearly defined. This study examined both clinical and socioeconomic predictors of DR-TB outcomes in the Eastern Cape, South Africa. Methods: A retrospective cohort analysis was conducted using routinely collected data. Outcomes were collapsed into successful (cured/completed) and unsuccessful (failure, death, loss to follow-up). Descriptive statistics and cross-tabulations compared outcome distributions across demographic, socioeconomic, and clinical variables. Logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Random forest modelling assessed predictive performance and ranked feature importance. Results: Cross-tabulations showed significant associations between treatment outcome and gender (p=0.046), income (p=0.0037), and DR-TB type (p=0.0355). Logistic regression confirmed that males had higher odds of success than females (OR=2.11, 95% CI: 1.05–4.21), while salaried patients performed better than those without income (OR=3.46, 95% CI: 0.39–30.96). Pre-XDR TB was associated with reduced odds of success compared to RR-TB (OR=0.25, 95% CI: 0.05–1.19). The logistic model showed modest discrimination (AUC≈0.55). Random forest modelling achieved superior performance and identified age as the most important predictor, followed by patient category, income, social history, education, and DR-TB type. Conclusion: Both clinical and social factors shape DR-TB outcomes. Gender, income, and resistance patterns were consistently influential, while machine-learning analysis highlighted age and socioeconomic determinants. Integrated strategies addressing biomedical and social drivers are essential to improve treatment success in high-burden settings.